Free Trial
LON:DXRX

Diaceutics 5/13/2025 Earnings Report

Diaceutics logo
GBX 161 -1.00 (-0.62%)
As of 11:22 AM Eastern

Diaceutics EPS Results

Actual EPS
-GBX 2.02
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Diaceutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Diaceutics Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Diaceutics Earnings Headlines

Nick Roberts Acquires 91 Shares of Diaceutics (LON:DXRX) Stock
Options Pro Reveals His #1 Retirement Income Trade
Most traders don’t realize there’s a window of time each day when price movements become highly predictable — and I’ve built a strategy designed to capitalize on it. One user reportedly earned thousands in his first few months using this approach, though results always vary. The key is timing and consistency, not luck or leverage.tc pixel
See More Diaceutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Diaceutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Diaceutics and other key companies, straight to your email.

About Diaceutics

At Diaceutics (LON:DXRX) we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.

View Diaceutics Profile

More Earnings Resources from MarketBeat